Table 1.
Association between clusters and mortality during the first (0–6 years) and second (6–12 years) follow-up.
| Multimorbidity clusters at baseline | Events/at risk (%) | OR (95% CI)* 0–6 years mortality |
Multimorbidity clusters at 6 years | Events/at risk | OR (95% CI)* 6–12 years mortality |
|---|---|---|---|---|---|
| Psychiatric and respiratory diseases | 35/159 (22) | 1.60 (1.02–2.51) | Heart and vascular diseases | 37/76 (49) | 3.78 (2.13–6.70) |
| Heart diseases | 146/277 (53) | 3.07 (2.26–4.19) | Heart diseases and cognitive impairment | 93/152 (61) | 3.73 (2.41–5.79) |
| Eye diseases and cancer | 105/305 (34) | 1.23 (0.90–1.68) | Neuropsychiatric and respiratory dis. | 143/265 (54) | 4.30 (2.95–6.27) |
| Cognitive and sensory impair. | 233/306 (76) | 6.00 (4.21–8.54) | Eye diseases | 79/227 (35) | 1.33 (0.89–2.00) |
| Respiratory and MSK diseases | 91/456 (20) | 1.29 (0.96–1.74) | MSK, respiratory, and immune diseases | 32/238 (13) | 1.06 (0.67–1.70) |
| Unspecific group | 203/1428 (14) | Ref. | Unspecific group | 93/758 (12) | Ref. |
To note, for this analysis participants were assigned to the cluster they were more likely to belong.
Asterisk adjusted for age, sex, and education.
OR odds ratio; CI confidence interval; MSK musculoskeletal.